Maine regulators are again pushing to “modernize” the state’s medical cannabis program after a report showed that 42% of samples they recently tested contained contaminants such as yeast and pesticides.
Maine’s Office of Cannabis Policy (OCP) found that 50 of the 120 samples they tested in this round of audit testing would have failed under the lab-testing standards for adult-use cannabis in the state, according to a news release.
“This data (indicates) that Maine’s medical cannabis program needs a comprehensive solution to reform and modernize the system in order to protect Maine’s patients,” OCP Director John Hudak said in a statement.
Medical cannabis in Maine is not subject to the same lab-testing requirements as adult-use marijuana, and efforts to change that have been met with resistance from cultivators and caregivers in the program who say their products are safe.
According to the OCP, of the
Read full article on Marijuana Business Daily